Cargando…
Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
The past decades witnessed a significant stride in deciphering the pathophysiology of inflammatory bowel disease, which further advanced drug development adding several new biologicals and small molecules to the arsenal of available therapies. Surprisingly, this wealth in therapeutic options did not...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818904/ https://www.ncbi.nlm.nih.gov/pubmed/35146421 http://dx.doi.org/10.1016/j.crphar.2022.100089 |